|
Aaron Industries
|
|
|
|
Aaron Industries Limited has informed the Exchange about Copy of Newspaper Publication
|
|
|
Aelea Commodities
|
|
|
|
Audited Results & Half Yearly Results & Inter alia, to consider and approve:- 2. The appointment of an Additional Director (Non-Executive, Independent) on the Board of the Company, subject to applicable approvals, if any; and 3. 3. To transact such other business(es) as may be considered necessary with the permission of the Chair.
|
|
|
Aesthetik Engineers
|
|
|
|
Aesthetik Engineers Limited has submitted the Exchange a copy of Scrutinizers report along with Voting Results of Court Convened General Meeting held on May 15, 2026.
|
|
|
Anondita Medicare
|
|
|
|
Anondita Medicare Limited has informed the Exchange regarding Corrigendum to Notice of 01/2026-27 Extra Ordinary General Meeting
|
|
|
Anuroop Packaging
|
|
|
|
Dear sir mam, this is in reference to clarification sought from Anuroop Packaging Limited, please note that the company is in compliance with all regulations including Regulation 30 of SEBI (LODR) Regulation 2015 , the company have been regular in providing details of all the events, information and price sensitive information which have bearing on the operational performance of the company to the exchange within prescribe timeline. We further confirm that, there are no pending announcement, events on information which is/are price sensitive that might have led to significant movement in the price behavior of the companies shares. The movement in price of the shares is purely market driven. You are requested to take the same on record. Thanking You
|
|
|
Avi Ansh Textile
|
|
|
|
Avi Ansh Textile Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
|
|
|
Avi Ansh Textile
|
|
|
|
Avi Ansh Textile Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
|
|
|
Avp Infracon
|
|
|
|
AVP Infracon Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
|
|
|
Bal Pharma
|
|
|
|
Employees Stock Option Plan & Audited Results & Final Dividend
|
|
|
Cell Point (india)
|
|
|
|
Cell Point (India) Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
|
|
|
|
|
|